Hugh Haydon

522 total citations
7 papers, 377 citations indexed

About

Hugh Haydon is a scholar working on Biotechnology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Hugh Haydon has authored 7 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biotechnology, 6 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Hugh Haydon's work include Transgenic Plants and Applications (7 papers), CRISPR and Genetic Engineering (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Hugh Haydon is often cited by papers focused on Transgenic Plants and Applications (7 papers), CRISPR and Genetic Engineering (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Hugh Haydon collaborates with scholars based in United States, South Africa and Cuba. Hugh Haydon's co-authors include Gregory P. Pogue, Stefan Herz, Victor Klimyuk, John E. Butler, Barry Bratcher, Ernie Hiatt, Michael Pauly, Larry Zeitlin, Kevin J. Whaley and Rachel Chikwamba and has published in prestigious journals such as Methods in enzymology on CD-ROM/Methods in enzymology, Plant Biotechnology Journal and Current topics in microbiology and immunology.

In The Last Decade

Hugh Haydon

7 papers receiving 362 citations

Peers

Hugh Haydon

BIOTE

MB

PS

IMMUN

ID

Andrew G. Diamos United States

Matthew Dent United States

Audrey Y‐H. Teh United Kingdom

Michael A. Eldarov Russia

Emmanuel Margolin South Africa

Lotte B. Westerhof Netherlands

Vikram Virdi Belgium

Pierre‐Olivier Lavoie Canada

Narach Khorattanakulchai Thailand

Julia Pinkhasov United States

Andrew G. Diamos United States

Hugh Haydon

224 ×0.7

BIOTE

227 ×0.9

MB

127 ×1.3

PS

71 ×1.0

IMMUN

65 ×1.1

ID

Citations per year, relative to Hugh Haydon Hugh Haydon (= 1×) peers Andrew G. Diamos

Countries citing papers authored by Hugh Haydon

Since Specialization

Citations

This map shows the geographic impact of Hugh Haydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Haydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Haydon more than expected).

Fields of papers citing papers by Hugh Haydon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Haydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Haydon. The network helps show where Hugh Haydon may publish in the future.

Co-authorship network of co-authors of Hugh Haydon

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Haydon. A scholar is included among the top collaborators of Hugh Haydon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Haydon. Hugh Haydon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Swope, Kelsi, Josh Morton, Gregory P. Pogue, et al.. (2022). Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana. mAbs. 14(1). 2013594–2013594. 15 indexed citations

2.

Royal, Joshua M., Carrie A. Simpson, Alison A. McCormick, et al.. (2021). Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Vaccines. 9(11). 1347–1347. 48 indexed citations

3.

Swope, Kelsi, Josh Morton, Gregory P. Pogue, et al.. (2021). Manufacturing plant-made monoclonal antibodies for research or therapeutic applications. Methods in enzymology on CD-ROM/Methods in enzymology. 660. 239–263. 8 indexed citations

4.

K‐C., Julian, Paul Christou, Rachel Chikwamba, et al.. (2013). Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies. Plant Biotechnology Journal. 11(9). 1029–1033. 45 indexed citations

5.

Mallajosyula, Jyothi K., Ernie Hiatt, Trushar Jeevan, et al.. (2013). Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge. Human Vaccines & Immunotherapeutics. 10(3). 586–595. 42 indexed citations

6.

Klimyuk, Victor, Gregory P. Pogue, Stefan Herz, John E. Butler, & Hugh Haydon. (2012). Production of Recombinant Antigens and Antibodies in Nicotiana benthamiana Using ‘Magnifection’ Technology: GMP-Compliant Facilities for Small- and Large-Scale Manufacturing. Current topics in microbiology and immunology. 375. 127–154. 84 indexed citations

7.

Pogue, Gregory P., Fakhrieh Vojdani, Kenneth E. Palmer, et al.. (2010). Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems. Plant Biotechnology Journal. 8(5). 638–654. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact